Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on February 10, 2023 has approved the unaudited financial results for the quarter and nine months ended December 31, 2022 (Standalone and Consolidated) as enclosed. It enclosed the Limited Review Report dated February 10, 2023 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, S R B C & Co. LLP. The Board meeting commenced at 11.45 am and concluded at 01.00 pm.
The above information is a part of company’s filings submitted to BSE.
